drugset
drugset / Trial / NCT01305512

Pharmacokinetic, Safety and Tolerability Study of SPARC1028

NCT01305512 ↗

Phase 1 Completed 36 enrolled Sun Pharma Advanced Research Company Limited
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of pharmacokinetic profile of SPARC1028

Timeline

Start
2012-05
Primary completion
2016-06
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject SPARC1028 Unknown — Intravenous

Indications

No indication recorded.